ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Session » Rheumatoid Arthritis – Clinical Aspects - Poster II: Co-morbidities and Complications

Date: Monday, November 14, 2016

Time: 9:00AM-11:00AM

Meeting: 2016 ACR/ARHP Annual Meeting

9:00AM-11:00AM
Abstract Number: 1540
“I Am Always in Pain Somewhere”: Continuing Unmet Need in Rheumatoid Arthritis
9:00AM-11:00AM
Abstract Number: 1499
Anti-Cyclic Citrullinated Peptide Antibodies and Severity of Interstitial Lung Disease with Rheumatoid Arthritis
9:00AM-11:00AM
Abstract Number: 1547
Antibodies Against Carbamylated Proteins in Belgian RA Patients and in Other Rheumatic Diseases
9:00AM-11:00AM
Abstract Number: 1527
Anxiety Sensitivity on Indicators of Disease Severity Among Patients with Inflammatory Arthritis
9:00AM-11:00AM
Abstract Number: 1556
Assessment of the Burden of Comorbidities By the Rheumatic Disease Comorbidity Index in Early Rheumatoid Arthritis Patients at Disease Onset
9:00AM-11:00AM
Abstract Number: 1534
Assessment of the Relationship of the Static and Dynamic Balance Parameters with Clinical, Functional and Radiological Findings in Patients with Rheumatoid Arthritis
9:00AM-11:00AM
Abstract Number: 1486
Associations Between Heart Rate Adjusted ST Segment and Heart Rate Variability in Patients with Rheumatoid Arthritis
9:00AM-11:00AM
Abstract Number: 1492
Biomarker-Related Risk for Myocardial Infarction and Serious Infections in Patients with Rheumatoid Arthritis: A Population-Based Study
9:00AM-11:00AM
Abstract Number: 1512
Bone Structural Deficits in Rheumatoid Arthritis: Impact of Muscle Mass and Density
9:00AM-11:00AM
Abstract Number: 1479
Cardiovascular Diseases and Mortality Are Independently Influenced By Carotid Plaque Presence in Rheumatoid Arthritis: The 5-Year Prospective Study
9:00AM-11:00AM
Abstract Number: 1466
Cardiovascular Risk Assessment in Persons with Rheumatoid Arthritis: A Correlative Study of Non-Invasive Arterial Health Testing with the Inflammatory Burden of Disease
9:00AM-11:00AM
Abstract Number: 1467
Cardiovascular Risk Assessment in Persons with Rheumatoid Arthritis: Non-Invasive Arterial Health Testing to Assess Subclinical Risk of Cardiovascular Disease
9:00AM-11:00AM
Abstract Number: 1546
Clinical Features at the Onset of Lymphoproliferative Disorder in Patients with Rheumatoid Arthritis
9:00AM-11:00AM
Abstract Number: 1550
Comorbidities of Rheumatoid Arthritis: Results from the Korean National Health and Nutrition Examination Survey
9:00AM-11:00AM
Abstract Number: 1475
Comparative Risk of Cardiovascular Outcomes Between Topical and Oral Non-Selective Nsaids in Taiwanese Rheumatoid Arthritis Patients
9:00AM-11:00AM
Abstract Number: 1472
Comparison Between Carotid Plaque and Carotid Intima-Media Thickness to Detect Subclinical Atherosclerosis in Rheumatoid Arthritis
9:00AM-11:00AM
Abstract Number: 1488
Comparison Between Carotid Ultrasonography and Coronary Artery Calcification Score to Detect Subclinical Atherosclerosis in Rheumatoid Arthritis
9:00AM-11:00AM
Abstract Number: 1487
Comparison Between Intima-Media Thickness and Coronary Artery Tomography in Subclinical Atheroesclerosis Detection in Rheumatoid Arthritis
9:00AM-11:00AM
Abstract Number: 1500
Concomitant Development of Interstitial Pneumonia Associated with Dermatomyositis and Rheumatoid Arthritis
9:00AM-11:00AM
Abstract Number: 1478
Coronary Artery Calcification in Rheumatoid Arthritis Patients Is Not Characterized By an Increase in Genes Associated with Coronary Artery Disease in the General Population
9:00AM-11:00AM
Abstract Number: 1469
Coronary Territories Are Not Affected in Mexican Mestizo Patients with Rheumatoid Arthritis in Comparison to Matched Controls: Evaluation Using Speckle Tracking Echocardiography
9:00AM-11:00AM
Abstract Number: 1548
Correlates of Fatigue in People Living with Rheumatoid Arthritis
9:00AM-11:00AM
Abstract Number: 1515
Could Increase Levels of Dickkopf-1 Protein be Considered As a Potential Biomarker for Bone Resorption in Joint and Periodontal Disease in Patients with Early Rheumatoid Arthritis?
9:00AM-11:00AM
Abstract Number: 1553
Declining Flare Rates in the First Five Years of RA Disease, but Not after
9:00AM-11:00AM
Abstract Number: 1531
Decrease in Bone Mineral Density during Three Months of Early RA Measured By DXR Predicts Radiographic Joint Damage after One Year
9:00AM-11:00AM
Abstract Number: 1535
Depression in Rheumatoid Arthritis
9:00AM-11:00AM
Abstract Number: 1480
Determination of the Lipid Profile in Active Disease Leads to Incorrect Cardiovascular Risk Prediction in Early Rheumatoid Arthritis Patients
9:00AM-11:00AM
Abstract Number: 1476
Diastolic Dysfunction in Patients with Rheumatoid Arthritis: Predictors of Longitudinal Progression over Five Years
9:00AM-11:00AM
Abstract Number: 1522
Disease Burden in Rheumatoid Arthritis (RA) Patients Who Have Secondary Osteoarthritis (OA) Is Lower Than in OA but Higher Than in RA with No Secondary OA
9:00AM-11:00AM
Abstract Number: 1521
Disease Characteristics and Change of Arthritis Activity According to Treatment in Hepatitis B Surface Antigen Positive Rheumatoid Arthritis Patients
9:00AM-11:00AM
Abstract Number: 1517
Does Inflammatory Arthritis Really Improve during Pregnancy? a Systematic Review and Meta-Analysis
9:00AM-11:00AM
Abstract Number: 1555
E-Comorbidity: Evaluation of the Validity of Electronic Comorbidity Assessment in Identifying Comorbid Conditions Among Patients with Rheumatoid and Psoriatic Arthritis
9:00AM-11:00AM
Abstract Number: 1483
Elevated Anti-Cyclic Citrullinated Peptide Antibody Titer Is Associated with Increased Cardiovascular Risk
9:00AM-11:00AM
Abstract Number: 1516
Evidence of Labial Salivary Gland Epithelial Cell Activation from Patients with Rheumatoid Arthritis and Sicca Symptomatology
9:00AM-11:00AM
Abstract Number: 1477
Exploring the Inadequate Cardiovascular Disease Prevention in Inflammatory Joint Diseases: Results from a Nationwide Norwegian Project
9:00AM-11:00AM
Abstract Number: 1484
Exploring the Link Between RA Disease Activity, Lipid Levels, and Cardiovascular Disease in an Early Inflammatory Arthritis Cohort
9:00AM-11:00AM
Abstract Number: 1473
Expression of Vitamin D Receptor Associated Genes in the Aorta of Coronary Artery Disease Patients with and without Rheumatoid Arthritis
9:00AM-11:00AM
Abstract Number: 1504
Fluoroquinolone Resistance in Escherichia coli Urinary Tract Infections Among Patients with Rheumatoid Arthritis: Does Use of Hydroxichloroquine Matter?
9:00AM-11:00AM
Abstract Number: 1541
Frailty Is Associated with Decreased Physical Function in Adults with Rheumatoid Arthritis
9:00AM-11:00AM
Abstract Number: 1513
FRAX Fracture Risk in Rheumatoid Arthritis – Assessments with and without Bone Mineral Density May Lead to Very Different Results in Individual Patients
9:00AM-11:00AM
Abstract Number: 1485
Generation of New Carotid Plaque Is Determined By the Prexisting Carotid Atherosclerosis and Ongoning Disease Activity of Rheumatoid Arthritis
9:00AM-11:00AM
Abstract Number: 1519
How Much, and When, Does Autoimmune Thyroid Disease Increase the Risk of RA, and Does RA-Onset Impact the Risk of Autoimmune Thyroid Disease?
9:00AM-11:00AM
Abstract Number: 1518
Immunoglobulin Binding Protein (BiP), an Antigen for CCP Sero-Positive Rheumatoid Arthritis Patients, Can Result in a False Positive Quantiferon-Gold Tuberculosis Test
9:00AM-11:00AM
Abstract Number: 1511
Impacts of Disease Activity and Serum Level of Neurotrophic Factors on Depression in Rheumatoid Arthritis
9:00AM-11:00AM
Abstract Number: 1489
Incident Hypertension and Associated Factors in a Hispanic Group with Rheumatoid Arthritis
9:00AM-11:00AM
Abstract Number: 1509
Increased Fracture Risk in Patients with Early Rheumatoid Arthritis in the 1990s As Well As in the 2000s: A Prospective General Population-Matched Cohort Study
9:00AM-11:00AM
Abstract Number: 1474
Increased Levels of Lipoprotein(a) in RA Patients with Cardiovascular Disease
9:00AM-11:00AM
Abstract Number: 1468
Increased Mitral and Tricuspid Valve Regurgitation Among Mexican Mestizo Patients with Rheumatoid Arthritis
9:00AM-11:00AM
Abstract Number: 1528
Incretin Axis in Non Diabetic Rheumatoid Arthritis Patients
9:00AM-11:00AM
Abstract Number: 1495
Lipoprotein(a) Concentrations in Rheumatoid Arthritis on Biologic Therapy: Results from the Cardiovascular in Rheumatology [CARMA] Study Project
9:00AM-11:00AM
Abstract Number: 1554
Longitudinal Trajectories of the Weighted Lansbury Articular Indices and Standard Joint Counts Are Similarly Correlated with Trajectories of Physical Function in Early Inflammatory Arthritis
9:00AM-11:00AM
Abstract Number: 1538
Lower Ratings of Pain Intensity in Older Adults Lead to Underestimation of Disease Activity By Disease Activity Score 28-C-Reactive Protein (DAS28-CRP) in Patients with Rheumatoid Arthritis
9:00AM-11:00AM
Abstract Number: 1491
M-Ficolin and MAp44 As Potential Markers of Subclinical Cardiovascular Comorbidity; Cardiac Evaluation By Coronary Computer Tomography and Myocardial Deformation of Left Ventricle in Early Rheumatoid Arthritis Patients
9:00AM-11:00AM
Abstract Number: 1490
Metabolic and Cardio-Vascular Benefits of Hydroxychloroquine in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
9:00AM-11:00AM
Abstract Number: 1542
Metabolic Syndrome and Cardiovascular Risk Factors in Brazilian Patients with Established Rheumatoid Arthritis 
9:00AM-11:00AM
Abstract Number: 1470
Moderate to Severe Disease Activity in Rheumatoid Arthritis  Is Associated with Myocardial  18f-Fluorodeoxyglucose (18F-FDG) Uptake
9:00AM-11:00AM
Abstract Number: 1471
Myocardial 18f-Fluorodeoxyglucose (18F-FDG) Uptake in RA Patients without Clinical Cardiovascular Disease Is Higher Than in Controls and Decreases with Treatment
9:00AM-11:00AM
Abstract Number: 1494
Myocardial Structure, Function, and Fibrosis in Patients with Rheumatoid Arthritis and Matched Control Subjects
9:00AM-11:00AM
Abstract Number: 1543
Obese Patients with RA Have a More Seropositive and a More Active Disease with Less Deformities
9:00AM-11:00AM
Abstract Number: 1506
One Third of Patients with Established Rheumatoid Arthritis (RA) Are Correctly Vaccinated Against Influenza and Pneumococcus and This Is Increasing: 3 Year Longitudinal Assessment of 776 Patients
9:00AM-11:00AM
Abstract Number: 1507
Our Strategy of Preventing Tuberculosis (TB) in Patients with Rheumatic Diseases Under the Treatment with Biologic Dmards
9:00AM-11:00AM
Abstract Number: 1525
Pain, Physical Function, and Worry (But Not Depression and Poor Sleep) Lead to Greater Fatigue in RA
9:00AM-11:00AM
Abstract Number: 1503
Patterns and Factors Associated with Immunization Among Adult Patients with Rheumatic Diseases in the US
9:00AM-11:00AM
Abstract Number: 1498
Patterns of Interstitial Lung Disease and Associated Mortality in Rheumatoid Arthritis
9:00AM-11:00AM
Abstract Number: 1539
Physician-Reported and Patient-Reported Anxiety and Depression in Rheumatoid Arthritis
9:00AM-11:00AM
Abstract Number: 1533
Pregnancy Outcomes in Women with Rheumatoid Arthritis : A Systematic Review and Meta-Analyses
9:00AM-11:00AM
Abstract Number: 1508
Prevalence and Clinical Characteristics of Rheumatoid Arthritis in Sickle Cell Patients: A Cross-Sectional Analysis
9:00AM-11:00AM
Abstract Number: 1537
Prevalence and Impact of Inflammatory Multimorbid Conditions on Trajectories of Disease Activity in the First Year of Follow-up in a Multi-Center Era Cohort
9:00AM-11:00AM
Abstract Number: 1497
Progressive Decline of Lung Function in Rheumatoid Arthritis Associated Interstitial Lung Disease
9:00AM-11:00AM
Abstract Number: 1520
RA Flare after Total Hip and Total Knee Arthroplasty: Preliminary Outcomes at 1 Year
9:00AM-11:00AM
Abstract Number: 1549
Rheumatoid Arthritis and Periodontal Disease: Salivary ACPA Levels and Clinical Presentation
9:00AM-11:00AM
Abstract Number: 1551
Rheumatoid Arthritis Is Associated with Low-/Mid-Frequency Hearing Impairment: Data from the Korean National Health and Nutrition Examination Survey
9:00AM-11:00AM
Abstract Number: 1496
Risk for Serious Infection in Rheumatoid Arthritis Associated Interstitial Lung Disease
9:00AM-11:00AM
Abstract Number: 1493
Screening Patterns for Hyperlipidemia Among Patients with Rheumatoid Arthritis Based on Patterns of Care from By Primary Care Physicians, Rheumatologists or Both
9:00AM-11:00AM
Abstract Number: 1526
Serum  y-Neuropeptide Levels and Its Relationship with Body Fat Mass and Clinical Characteristics in Rheumatoid Arthritis
9:00AM-11:00AM
Abstract Number: 1529
Serum Levels of P-Glycoprotein Are Associated with Disease Activity in Rheumatoid Arthritis
9:00AM-11:00AM
Abstract Number: 1544
Serum Omentin-1 Levels and Metabolic Syndrome in Women with Rheumatoid Arthritis
9:00AM-11:00AM
Abstract Number: 1536
Sleep Disturbance in Patients with Rheumatoid Arthritis – a Cross-Section Study
9:00AM-11:00AM
Abstract Number: 1532
Sleep Hygiene Practices and Associations with Patient-Reported Outcomes in Rheumatoid Arthritis
9:00AM-11:00AM
Abstract Number: 1481
Success Rate of Blood Pressure Goal Achievement in Patients with Inflammatory Joint Diseases
9:00AM-11:00AM
Abstract Number: 1524
Suppletion Therapy May be Warranted in RA Patients with Co-Existent Subclinical Hypothyroidism
9:00AM-11:00AM
Abstract Number: 1514
Symptoms of Depression and Anxiety Predict Worse Disease Activity and Functional Disability in a Cohort of Established Rheumatoid Arthritis Patients
9:00AM-11:00AM
Abstract Number: 1530
Temporal Trend of Total Joint Replacement in Rheumatoid Arthritis Patients: A Survival Study
9:00AM-11:00AM
Abstract Number: 1552
The Association of Fatigue, Comorbidities and Anti Rheumatic Drugs in Rheumatoid Arthritis: Results from French Cohort Study of Comorbidities
9:00AM-11:00AM
Abstract Number: 1523
The Effect Size of Fibromyalgia on PG-VAS in Rheumatoid Arthritis Patients. Adjustment Proposal in DAS28-ESR
9:00AM-11:00AM
Abstract Number: 1501
The Incidence of Interstial Lung Disease and Malignancies in Veterans with Rheumatoid Arthritis
9:00AM-11:00AM
Abstract Number: 1505
Trends in Hospitalizations for Infections in US Patients with Rheumatoid Arthritis, 1993-2013
9:00AM-11:00AM
Abstract Number: 1510
Trends in the Occurrence of Malignancy in Japanese Patients with Rheumatoid Arthritis Based on the Institute of Rheumatology, Rheumatoid Arthritis (IORRA) Cohort during a 14-Year Observation Period
9:00AM-11:00AM
Abstract Number: 1464
Utility of Relative Cardiovascular Risk Score Scales and Vascular Age Predictors in Patients with Reumathoid Arthritis UNDER 50 YEARS of Age
9:00AM-11:00AM
Abstract Number: 1465
Utility of Relative Cardiovascular Risk Score Scales in Patients UNDER the Age of 50 and Its Association with the Presence of Carotid Atherosclerosis in the Ultrasound
9:00AM-11:00AM
Abstract Number: 1502
Vaccination Program to Prevent Hospital Admissions Due to Serious Respiratory Infections in Rheumatoid Arthritis Patients. Prosprective Study of 294 Patients
9:00AM-11:00AM
Abstract Number: 1545
Vitamin D Insufficiency in Patients with Rheumatoid Arthritis and Healthy Controls and Correlation Between Vitamin D Levels and Disease Activity and Disability in RA Patients
9:00AM-11:00AM
Abstract Number: 1482
Web-Based PILOT Intervention Study to Improve Cardiovascular Risk Knowledge Among Rheumatoid Arthritis Patients

« View all sessions from this meeting

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology